See news from the full history of Samplix, covering all the conferences we've attended, new product launches, and more.
December 17-18
In the agenda: Xdrop Technology for targeted enrichment of genomic regions for long- and short-read sequencing. Presented by Peter Mouritzen, Vice President Application and Market Development, Samplix
December 1-3
In the agenda: A pivotal contribution to CRISPR-editing validation. Presented by Cristina Gamba, Global Product Manager, Samplix
November 19-20
In the agenda: Discover Xdrop: Whole Genome Amplification (WGA) in droplets for single cells. Presented by Peter Mouritzen, Vice President Application and Market Development, Samplix
November 5-6
The conference included the following talks:
October 1, 2020
Samplix has launched a new CRISPR validation service using its Xdrop platform. This proprietary technology from Samplix can enrich genomic regions longer than 100 kb from as little as 1 ng genomic DNA and with single-molecule resolution.
To read more, please see the full press release here.
We have received an overwhelming number of very high quality applications, so we decided to award 4 grants instead of 3. All applications have been carefully reviewed by a team of 5 Samplix scientists.
June 30, 2020
The webinar had the following program:
PART 1: Tackling Disease-Related Repeat-Expansion Analysis. Presented by Marzia Rossato, Researcher, Functional Genomic Lab, University of Verona
PART 2: Validation of CRISPR in a 100 kb Region Surrounding the Editing Site. Presented by Peter Mouritzen, Vice President Application and Market Development, Samplix
PART 3: The Launch of a Grant Program and Q&A
May 28, 2020
Bioneer provides customized gene editing services including advanced quality control of gene edited cell models and will through their partnership with Samplix offer their customers access to the Xdrop technology.
Learn more: Bioneer and CRISPR Editing Verification.
May 5, 2020
Today, Samplix launched its comprehensive service program to grant any laboratory access to the advantages of Xdrop technology.
To read more, please see the full press release here:
June 6-9
We attended at 2020's European Society for Human Genetics (ESHG) Conference in Berlin.
During ESHG, we presented our Xdrop instrument.
March 12, 2020
Samplix attended and presented at the Genome Editing 2020 conference, in Oxford. Our speaker, Peter Mouritzen, Vice President Application and Market Development at Samplix, presented the following: Xdrop – A New Microfluidics Technology for the Analysis of CRISPR Editing.
March 4-5
Samplix demonstrated our recently launched Xdrop system at the 8th Plant and Gene Editing Congress in Rotterdam, Netherlands.
